Showing 1 posts of 1 posts found.
Novartis has bought the rights to licence and commercialise a novel anti-PGDF therapy which it is currently trialling in Phase …
Hot-tub therapy tested as potential treatment for peripheral artery disease
Raimond takes helm at Nuclera
Most advanced breast cancer patients treated in community settings, Phesi study finds
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
Bramacare opens supported-living facility for eating disorder recovery